Want to see JP:7061 full AI Analyst Report?

Japan Hospice Holdings Inc. (7061) Price & Analysis

0 Followers

7061 Stock Chart & Stats

¥1120.00

¥7.00(0.51%)

At close: Jan 08 4:00 PM EST

¥1120.00

¥7.00(0.51%)

Day’s Range― - ―

52-Week Range¥509.00 - ¥1,578.00

Previous CloseN/A

Volume53.20K

Average Volume (3M)47.89K

Market Cap

¥4.78B

Enterprise Value¥17.36K

Total Cash (Recent Filing)¥1.78B

Total Debt (Recent Filing)¥13.06B

Price to Earnings (P/E)15.7

Beta1.08

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.43%

Share Statistics

EPS (TTM)35.87

Shares Outstanding8,484,100

10 Day Avg. Volume91,680

30 Day Avg. Volume47,890

Financial Highlights & Ratios

PEG Ratio-0.59

Price to Book (P/B)2.56

Price to Sales (P/S)0.66

P/FCF Ratio-7.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)199.5

Revenue Forecast (FY)¥20.00B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthThe company has delivered steady top-line expansion over multiple years, including ~8% revenue growth in 2025. Durable demand for hospice and long-term care services supports sustained volume growth, enabling scale benefits and predictable service revenue over a multi-month horizon.

Positive Operating Cash FlowCore operations generated positive operating cash flow (~¥1.05B in 2025), indicating underlying cash-generating ability from service operations. Persistent positive OCF provides a foundation for funding working capital and supporting ongoing operations even if FCF remains challenged in the near term.

Reimbursement-linked Revenue ModelThe business earns fees largely via Japan’s public healthcare and long-term care reimbursements, creating structurally predictable revenue streams tied to regulated payment systems. This public-payor linkage tends to reduce volatility and underpins steady demand for hospice services over time.

Bears Say

High LeverageElevated leverage (~3.6x D/E) constrains financial flexibility and raises refinancing and interest-rate vulnerability. With substantial debt built up over years, the company faces limited capacity to absorb shocks or fund growth internally, increasing execution and liquidity risk over the medium term.

Consistently Negative Free Cash FlowPersistent negative free cash flow, and deep deficits in 2024–2025, signal that operations and investments are not producing surplus cash. This trend pressures liquidity, forces reliance on external financing, and undermines the company’s ability to self-fund capital needs over a sustained 2–6 month outlook.

Margin And Profitability DeteriorationSharp compression in gross and net margins, with net income falling despite higher revenue, indicates worsening cost structure or weaker pricing power. Reduced operating leverage and margin erosion impair returns and make earnings generation less resilient across business cycles and regulatory adjustments.

7061 FAQ

What was Japan Hospice Holdings Inc.’s price range in the past 12 months?

Japan Hospice Holdings Inc. lowest stock price was ¥509.00 and its highest was ¥1578.00 in the past 12 months.

What is Japan Hospice Holdings Inc.’s market cap?

Japan Hospice Holdings Inc.’s market cap is ¥4.78B.

When is Japan Hospice Holdings Inc.’s upcoming earnings report date?

Japan Hospice Holdings Inc.’s upcoming earnings report date is Aug 14, 2026 which is in 2 days.

How were Japan Hospice Holdings Inc.’s earnings last quarter?

Japan Hospice Holdings Inc. released its earnings results on May 15, 2026. The company reported ¥9.43 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Japan Hospice Holdings Inc. overvalued?

According to Wall Street analysts Japan Hospice Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Japan Hospice Holdings Inc. pay dividends?

Japan Hospice Holdings Inc. pays a Annually dividend of ¥25 which represents an annual dividend yield of 4.43%. See more information on Japan Hospice Holdings Inc. dividends here

What is Japan Hospice Holdings Inc.’s EPS estimate?

Japan Hospice Holdings Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Japan Hospice Holdings Inc. have?

Japan Hospice Holdings Inc. has 8,484,100 shares outstanding.

What happened to Japan Hospice Holdings Inc.’s price movement after its last earnings report?

Japan Hospice Holdings Inc. reported an EPS of ¥9.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.834%.

Which hedge fund is a major shareholder of Japan Hospice Holdings Inc.?

Currently, no hedge funds are holding shares in JP:7061

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Japan Hospice Holdings Inc.

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.